Annual Net Income
-$61.23 M
+$31.86 M+34.23%
31 December 2023
Summary:
Assembly Biosciences annual net profit is currently -$61.23 million, with the most recent change of +$31.86 million (+34.23%) on 31 December 2023. During the last 3 years, it has risen by +$924.00 thousand (+1.49%). ASMB annual net income is now -1248.81% below its all-time high of -$4.54 million, reached on 31 December 2009.ASMB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$9.61 M
+$1.54 M+13.80%
30 September 2024
Summary:
Assembly Biosciences quarterly net profit is currently -$9.61 million, with the most recent change of +$1.54 million (+13.80%) on 30 September 2024. Over the past year, it has increased by +$4.81 million (+33.34%). ASMB quarterly net income is now -232.23% below its all-time high of $7.27 million, reached on 30 June 2020.ASMB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$40.80 M
+$4.81 M+10.54%
30 September 2024
Summary:
Assembly Biosciences TTM net profit is currently -$40.80 million, with the most recent change of +$4.81 million (+10.54%) on 30 September 2024. Over the past year, it has increased by +$31.86 million (+43.84%). ASMB TTM net income is now -2825.02% below its all-time high of -$1.40 million, reached on 31 March 2009.ASMB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | +33.3% | +43.8% |
| 3 y3 years | +1.5% | +48.9% | +62.6% |
| 5 y5 years | +32.5% | +61.5% | +57.8% |
ASMB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +52.9% | -5.9% | +84.0% | at high | +68.8% |
| 5 y | 5 years | at high | +52.9% | -232.2% | +84.0% | at high | +68.8% |
| alltime | all time | -1248.8% | +52.9% | -232.2% | +84.0% | -2825.0% | +68.8% |
Assembly Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.61 M(-13.8%) | -$40.80 M(-10.5%) |
| June 2024 | - | -$11.15 M(+22.9%) | -$45.61 M(-11.2%) |
| Mar 2024 | - | -$9.08 M(-17.2%) | -$51.35 M(-16.1%) |
| Dec 2023 | -$61.23 M(-34.2%) | -$10.96 M(-24.0%) | -$61.23 M(-15.7%) |
| Sept 2023 | - | -$14.42 M(-14.7%) | -$72.66 M(-10.7%) |
| June 2023 | - | -$16.90 M(-10.8%) | -$81.39 M(-8.5%) |
| Mar 2023 | - | -$18.95 M(-15.4%) | -$88.95 M(-4.4%) |
| Dec 2022 | -$93.09 M(-28.3%) | -$22.39 M(-3.2%) | -$93.09 M(-28.9%) |
| Sept 2022 | - | -$23.14 M(-5.4%) | -$130.95 M(+3.4%) |
| June 2022 | - | -$24.46 M(+5.9%) | -$126.61 M(+0.7%) |
| Mar 2022 | - | -$23.09 M(-61.7%) | -$125.75 M(-3.2%) |
| Dec 2021 | -$129.85 M(+108.9%) | -$60.26 M(+220.5%) | -$129.85 M(+19.1%) |
| Sept 2021 | - | -$18.80 M(-20.3%) | -$109.02 M(+16.5%) |
| June 2021 | - | -$23.59 M(-13.3%) | -$93.56 M(+49.2%) |
| Mar 2021 | - | -$27.20 M(-31.0%) | -$62.70 M(+0.9%) |
| Dec 2020 | -$62.15 M(-36.3%) | -$39.42 M(+1077.0%) | -$62.15 M(+24.8%) |
| Sept 2020 | - | -$3.35 M(-146.1%) | -$49.82 M(-30.3%) |
| June 2020 | - | $7.27 M(-127.3%) | -$71.46 M(-26.5%) |
| Mar 2020 | - | -$26.66 M(-1.6%) | -$97.24 M(-0.4%) |
| Dec 2019 | -$97.63 M(+7.6%) | -$27.08 M(+8.4%) | -$97.63 M(+1.0%) |
| Sept 2019 | - | -$25.00 M(+35.1%) | -$96.71 M(+3.7%) |
| June 2019 | - | -$18.50 M(-31.6%) | -$93.25 M(-8.2%) |
| Mar 2019 | - | -$27.05 M(+3.4%) | -$101.55 M(+11.9%) |
| Dec 2018 | -$90.75 M(+112.0%) | -$26.16 M(+21.5%) | -$90.75 M(+34.3%) |
| Sept 2018 | - | -$21.54 M(-19.7%) | -$67.60 M(+15.9%) |
| June 2018 | - | -$26.81 M(+65.0%) | -$58.33 M(+29.3%) |
| Mar 2018 | - | -$16.25 M(+440.3%) | -$45.13 M(+5.4%) |
| Dec 2017 | -$42.81 M(-3.3%) | -$3.01 M(-75.5%) | -$42.81 M(-16.6%) |
| Sept 2017 | - | -$12.27 M(-9.8%) | -$51.35 M(+1.4%) |
| June 2017 | - | -$13.60 M(-2.4%) | -$50.65 M(+7.3%) |
| Mar 2017 | - | -$13.93 M(+20.7%) | -$47.20 M(+6.6%) |
| Dec 2016 | -$44.26 M | -$11.55 M(-0.2%) | -$44.26 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$11.57 M(+14.0%) | -$40.46 M(+14.0%) |
| June 2016 | - | -$10.15 M(-7.6%) | -$35.51 M(+9.9%) |
| Mar 2016 | - | -$10.99 M(+41.8%) | -$32.30 M(+13.5%) |
| Dec 2015 | -$28.45 M(+19.6%) | -$7.75 M(+17.1%) | -$28.45 M(+5.6%) |
| Sept 2015 | - | -$6.62 M(-4.7%) | -$26.93 M(-14.0%) |
| June 2015 | - | -$6.94 M(-2.8%) | -$31.34 M(+16.7%) |
| Mar 2015 | - | -$7.14 M(+14.7%) | -$26.86 M(+12.9%) |
| Dec 2014 | -$23.79 M(+22.6%) | -$6.23 M(-43.5%) | -$23.79 M(+0.8%) |
| Sept 2014 | - | -$11.02 M(+346.3%) | -$23.61 M(+35.1%) |
| June 2014 | - | -$2.47 M(-39.3%) | -$17.47 M(-11.6%) |
| Mar 2014 | - | -$4.07 M(-32.7%) | -$19.75 M(+1.8%) |
| Dec 2013 | -$19.40 M(-21.7%) | -$6.05 M(+23.9%) | -$19.40 M(+13.2%) |
| Sept 2013 | - | -$4.88 M(+2.7%) | -$17.15 M(-2.7%) |
| June 2013 | - | -$4.75 M(+27.6%) | -$17.62 M(-13.4%) |
| Mar 2013 | - | -$3.72 M(-1.8%) | -$20.34 M(-18.0%) |
| Dec 2012 | -$24.79 M(-27.8%) | -$3.79 M(-29.2%) | -$24.79 M(-37.8%) |
| Sept 2012 | - | -$5.36 M(-28.3%) | -$39.86 M(-1.1%) |
| June 2012 | - | -$7.47 M(-8.6%) | -$40.30 M(+1.3%) |
| Mar 2012 | - | -$8.17 M(-56.7%) | -$39.80 M(+15.9%) |
| Dec 2011 | -$34.34 M(+124.6%) | -$18.86 M(+225.1%) | -$34.34 M(+38.2%) |
| Sept 2011 | - | -$5.80 M(-16.7%) | -$24.85 M(+19.3%) |
| June 2011 | - | -$6.96 M(+155.7%) | -$20.83 M(+30.2%) |
| Mar 2011 | - | -$2.72 M(-70.9%) | -$15.99 M(+5.5%) |
| Dec 2010 | -$15.29 M(+236.8%) | -$9.37 M(+427.3%) | -$15.16 M(+104.6%) |
| Sept 2010 | - | -$1.78 M(-16.5%) | -$7.41 M(+12.8%) |
| June 2010 | - | -$2.13 M(+12.7%) | -$6.57 M(+30.5%) |
| Mar 2010 | - | -$1.89 M(+16.8%) | -$5.03 M(+10.8%) |
| Dec 2009 | -$4.54 M(-48.3%) | -$1.62 M(+72.5%) | -$4.54 M(+55.3%) |
| Sept 2009 | - | -$936.80 K(+58.4%) | -$2.92 M(+47.2%) |
| June 2009 | - | -$591.30 K(-57.6%) | -$1.99 M(+42.4%) |
| Mar 2009 | - | -$1.40 M | -$1.40 M |
| Dec 2008 | -$8.79 M | - | - |
FAQ
- What is Assembly Biosciences annual net profit?
- What is the all time high annual net income for Assembly Biosciences?
- What is Assembly Biosciences annual net income year-on-year change?
- What is Assembly Biosciences quarterly net profit?
- What is the all time high quarterly net income for Assembly Biosciences?
- What is Assembly Biosciences quarterly net income year-on-year change?
- What is Assembly Biosciences TTM net profit?
- What is the all time high TTM net income for Assembly Biosciences?
- What is Assembly Biosciences TTM net income year-on-year change?
What is Assembly Biosciences annual net profit?
The current annual net income of ASMB is -$61.23 M
What is the all time high annual net income for Assembly Biosciences?
Assembly Biosciences all-time high annual net profit is -$4.54 M
What is Assembly Biosciences annual net income year-on-year change?
Over the past year, ASMB annual net profit has changed by +$31.86 M (+34.23%)
What is Assembly Biosciences quarterly net profit?
The current quarterly net income of ASMB is -$9.61 M
What is the all time high quarterly net income for Assembly Biosciences?
Assembly Biosciences all-time high quarterly net profit is $7.27 M
What is Assembly Biosciences quarterly net income year-on-year change?
Over the past year, ASMB quarterly net profit has changed by +$4.81 M (+33.34%)
What is Assembly Biosciences TTM net profit?
The current TTM net income of ASMB is -$40.80 M
What is the all time high TTM net income for Assembly Biosciences?
Assembly Biosciences all-time high TTM net profit is -$1.40 M
What is Assembly Biosciences TTM net income year-on-year change?
Over the past year, ASMB TTM net profit has changed by +$31.86 M (+43.84%)